BioRestorative Therapies, Inc. (BRTX) Financials

$1.81

south_east
-$0.01 (-0.58%)
Day's range
$1.81
Day's range
$1.82
$10M$10M$0$0-$10M-$10M-$20M-$20M-$30M-$30MEarning201820182019201920202020202120212022202220232023202420240%0%-20000%-20000%-40000%-40000%-60000%-60000%-80000%-80000%Profit Margin
Profit Margin
Revenue
Earnings

BRTX Income statement / Annual

Last year (2024), BioRestorative Therapies, Inc.'s total revenue was $401,000.00, an increase of 175.03% from the previous year. In 2024, BioRestorative Therapies, Inc.'s net income was -$8.98 M. See BioRestorative Therapies, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $401,000.00 $145,800.00 $119,800.00 $46,000.00 $77,000.00 $130,000.00 $111,000.00 $81,000.00 $36,355.00 $628,915.00
Cost of Revenue $28,072.00 $0.00 $280,666.00 $205,205.00 $0.00 $0.00 $0.00 $259,260.00 $102.00 $261,504.00
Gross Profit $372,928.00 $145,800.00 -$160,866.00 -$159,205.00 $77,000.00 $130,000.00 $111,000.00 -$178,260.00 $36,253.00 $367,411.00
Gross Profit Ratio 0.93 1 -1.34 -3.46 1 1 1 -2.2 1 0.58
Research and Development Expenses $5.35 M $4.03 M $3.51 M $729,058.00 $876,829.00 $1.72 M $1.51 M $2.15 M $2.88 M $2.11 M
General & Administrative Expenses $6.58 M $11.16 M $15.58 M $25.61 M $1.92 M $6.52 M $5.89 M $6.24 M $4.86 M $5.26 M
Selling & Marketing Expenses $0.00 $168,028.00 $0.00 $12,290.00 $28,281.00 $321,280.00 $352,204.00 $65,455.00 $86,451.00 $168,352.00
Selling, General & Administrative Expenses $6.58 M $11.33 M $15.58 M $25.62 M $1.95 M $6.84 M $6.25 M $6.30 M $4.95 M $5.43 M
Other Expenses $0.00 $0.00 -$110,518.00 -$16.18 M -$658,152.00 -$1.87 M -$1.42 M -$59,938.00 -$46,605.00 $1.13 M
Operating Expenses $11.93 M $15.37 M $18.98 M $26.35 M $2.83 M $8.56 M $7.76 M $8.46 M $7.83 M $7.54 M
Cost And Expenses $11.96 M $15.37 M $18.98 M $26.35 M $2.83 M $8.56 M $7.76 M $8.46 M $7.83 M $7.80 M
Interest Income $616,077.00 $552,293.00 $11,650.00 $1.82 M $1.64 M $5.14 M $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $0.00 $11,650.00 $1.82 M $1.64 M $5.14 M $3.22 M $1.09 M $763,944.00 $263,583.00
Depreciation & Amortization $0.00 $165,735.00 $120,544.00 $205,205.00 $151,963.00 $217,450.00 $240,372.00 $259,260.00 $258,425.00 $213,784.00
EBITDA -$11.56 M -$15.06 M -$18.85 M -$26.22 M -$9.48 M -$9.29 M -$9.06 M -$8.10 M -$7.61 M -$7.11 M
EBITDA Ratio -28.82 -103.26 -157.37 -569.97 -123.12 -71.47 -81.58 -99.98 -209.43 -11.3
Operating Income Ratio -28.82 -104.39 -158.38 -571.91 -35.74 -64.86 -68.9 -103.39 -214.48 -11.4
Total Other Income/Expenses Net $2.58 M $4.80 M $5.75 M -$18.00 M -$8.52 M -$6.22 M -$4.87 M -$1.07 M -$839,035.00 -$753,118.00
Income Before Tax -$8.98 M -$10.42 M -$18.49 M -$44.30 M -$11.27 M -$14.65 M -$12.52 M -$9.44 M -$8.64 M -$7.92 M
Income Before Tax Ratio -22.39 -71.45 -154.38 -963.12 -146.4 -112.68 -112.77 -116.6 -237.55 -12.6
Income Tax Expense $0.00 $0.00 -$479,256.00 -$14.36 M $981,993.00 $3.27 M -$1.65 M $1.03 M $717,339.00 $263,583.00
Net Income -$8.98 M -$10.42 M -$18.02 M -$29.94 M -$12.25 M -$17.92 M -$12.52 M -$9.44 M -$8.64 M -$7.92 M
Net Income Ratio -22.39 -71.45 -150.38 -650.84 -159.15 -137.85 -112.77 -116.6 -237.55 -12.6
EPS -1.16 -2.47 -4.98 -25.21 -31.05 -3217.82 -4269.37 -6181.06 -7356.3 -9580.99
EPS Diluted -1.16 -2.47 -4.98 -25.21 -31.05 -3217.82 -4269.37 -6181.06 -7356.3 -9580.99
Weighted Average Shares Out $7.76 M $4.22 M $3.62 M $1.19 M $394,704.00 $5,569.34 $2,932.00 $1,528.00 $1,174.00 $827.00
Weighted Average Shares Out Diluted $7.76 M $4.22 M $3.62 M $1.19 M $394,704.00 $5,569.34 $2,932.00 $1,528.00 $1,174.00 $827.00
Link